◆Anti-tumor drug-related experiments: establishment and efficacy evaluation of various CDX xenograft animal models, establishment of tumor-bearing animal models, tumor volume (relative tumor inhibition rate and TGI calculating, and tumor growth curves plotting), tumor weight (tumor growth inhibition rate calculating), animal body weight, mortality rate, life extension rate, comparison of superiority, non-inferiority, or equivalence with positive control drugs, ex vivo biochemical test, histopathology test, etc.

◆Respiratory system diseases: establishment of animal models of asthma, pulmonary fibrosis and COPD, ILD, etc., animal behavior and ex vivo biochemical test, histopathology test, etc., protein expression, flow cytometry; tracheal tension.

◆Metabolic system diseases: diabetes, fatty liver, animal models of liver fibrosis, obesity, hyperuricemia, atherosclerosis, etc.

◆Nervous system experiments: Establishment of animal models of Alzheimer's disease, Parkinson's disease, epilepsy, migraine, hearing and ear diseases, pains (CCI, Chung), psychological disorders, drug addiction, etc. with a series of electrophysiological tests, cognitive and behavioral tests, ex vivo biochemical test, histopathology test, etc.

◆Immune system diseases: establishment of animal models of respiratory disease (asthma, COPD), arthritis (CIA, AIA), multiple sclerosis, IgA nephropathy, psoriasisand, etc., comparison of superiority, non-inferiority, or equivalence with positive control drugs, ex vivo biochemical test, histopathology test, etc.

◆Urinary system diseases: drug-induced renal impairment, surgery-induced renal impairment, renal insufficiency, renal failure, etc.

◆Cardiovascular diseases:
Mouse myocardial infarction model, coronary heart disease model, etc.

◆Other types: diabetic foot model, premature ovarian failure model, MCAO model, etc.